This paper is in the following e-collection/theme issue:

Formative Evaluation of Digital Health Interventions (2410) Breast Cancer (206) Clinical Cancer Research (83) Clinical Information and Decision Making (1407) Innovations in Cancer Diagnostic and Decision Support (58)

Published on in Vol 6, No 12 (2022): December

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/37144, first published .
Effectiveness of Secondary Risk–Reducing Strategies in Patients With Unilateral Breast Cancer With Pathogenic Variants of BRCA1 and BRCA2 Subjected to Breast-Conserving Surgery: Evidence-Based Simulation Study

Effectiveness of Secondary Risk–Reducing Strategies in Patients With Unilateral Breast Cancer With Pathogenic Variants of BRCA1 and BRCA2 Subjected to Breast-Conserving Surgery: Evidence-Based Simulation Study

Effectiveness of Secondary Risk–Reducing Strategies in Patients With Unilateral Breast Cancer With Pathogenic Variants of BRCA1 and BRCA2 Subjected to Breast-Conserving Surgery: Evidence-Based Simulation Study

Authors of this article:

Jelena Maksimenko1 Author Orcid Image ;   Pedro Pereira Rodrigues2 Author Orcid Image ;   Miki Nakazawa-Miklaševiča3 Author Orcid Image ;   David Pinto4 Author Orcid Image ;   Edvins Miklaševičs3 Author Orcid Image ;   Genadijs Trofimovičs5 Author Orcid Image ;   Jānis Gardovskis6 Author Orcid Image ;   Fatima Cardoso4 Author Orcid Image ;   Maria João Cardoso4 Author Orcid Image
Article Authors Cited by (1) Tweetations (2) Metrics

Journals

  1. Bagdia A, Joshi S, Koppiker C. Unofficial report by BreastGlobal team: Highlights and insights from the 18th St. Gallen Breast Cancer Conference 2023. Breast Global Journal 2023;1(2):98 View